COVID-19 CG

COVID-19 CG tracks SARS-CoV-2 single-nucleotide variations (SNVs) and viral lineages to support analysis of viral evolution, geographic spread, and impacts on diagnostics, therapeutics, and vaccines.

Key Features:

• Comprehensive SNV and lineage repository: Provides a repository of SARS-CoV-2 single-nucleotide variations (SNVs) and viral lineage information for monitoring genetic changes over time.
• Customizable filters: Enables filtering of sequence data and mutation records by geographic location, collection date, gene, and mutation type.
• Spike RBD analysis: Allows targeted investigation of SNVs within the Spike protein receptor binding domain (RBD) across regions.
• Diagnostic primer assessment: Enables examination of mutations that may affect diagnostic primers.
• Emerging lineage detection: Identifies and reports emerging dominant viral lineages and specific mutations (e.g., S477N observed in Australia).

Scientific Applications:

• Therapeutics and testing development: Investigating Spike RBD SNVs across regions to inform development and testing of therapeutics.
• Diagnostic assay evaluation: Assessing mutations that could impact diagnostic primer binding and assay accuracy.
• Genomic surveillance: Monitoring emergence and geographic spread of dominant viral lineages to inform public health strategies.
• Research on viral biology and interventions: Supporting studies of transmission, evolution, emergence, immune interactions, diagnostics, therapeutics, vaccine development, and tracking interventions.

Methodology:

Filters sequences and associated metadata by geographic location, collection date, gene, and mutation type to track and report SARS-CoV-2 SNVs and viral lineage distributions.